Qube Research & Technologies (QRT)
TARA icon

Qube Research & Technologies (QRT)’s Protara Therapeutics TARA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Buy
1,045,516
+868,512
+491% +$4.13M ﹤0.01% 1747
2026
Q1 		$922K Buy
177,004
+62,673
+55% +$371K ﹤0.01% 2533
2025
Q4 		$609K Buy
+114,331
New +$636K ﹤0.01% 2741
2025
Q2 		– Sell
-61,917
Closed -$264K – 3964
2025
Q1 		$264K Buy
+61,917
New +$277K ﹤0.01% 2778
2024
Q3 		– Sell
-2
Closed -$4 – 4090
2024
Q2 		$4 Hold
2
– – ﹤0.01% 3665
2024
Q1 		$8 Hold
2
– – ﹤0.01% 4309
2023
Q4 		$4 Hold
2
– – ﹤0.01% 4221
2023
Q3 		$3 Buy
+2
New +$5 ﹤0.01% 3997

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TARA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Protara Therapeutics (TARA) stake by 491% in Q2 2026, buying an estimated $4.13M and bringing the position to 1,045,516 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1747.

Qube Research & Technologies (QRT) first reported a position in TARA in Q3 2023 and has held it in 8 quarters since. 119 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Qube Research & Technologies (QRT) held 1,045,516 shares of Protara Therapeutics worth $3.99M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 868,512 Protara Therapeutics shares in Q2 2026, an estimated $4.13M.
  • Protara Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1747 holding.
  • Qube Research & Technologies (QRT) first reported a position in Protara Therapeutics in Q3 2023 and has held it in 8 quarters since.
  • 119 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.